The clinic said normal. The hospital said cellulitis.
The patient paid $4,326.30 and says 400 mL of a product described as hyaluronic acid was injected into her hips, thighs, and buttocks. Days later, severe pain, heat, swelling, and stiffness led her to the emergency department and a cellulitis diagnosis.
AI-assisted editorial analysis based on the linked patient discussion and named sources.Educational only—not medical advice. How we write
The search moment
What symptoms after buttock filler mean I should stop waiting and seek urgent care?
Red flags
Heat + severe pain
Diagnosis reported
Cellulitis
Priority
Urgent care
Compare real results
Do not compare body-contouring options by downtime alone
Compare the material, anatomical plane, facility, emergency plan, and the evidence behind the procedure.
Research BBL results400 mL
Reported volume
$4,326
Reported price
Hospitalized
Outcome
The product identity was not confirmed in the post. The patient reported being told it was HA while hospital staff sought the brand and composition. The cover is a still life, not a patient image.
Here is what the original post actually said.
The worsening symptoms
"The pain, heat, swelling, and stiffness worsened, so I went to the ER."
What the hospital said
"They confirmed I was at risk of sepsis."
The unanswered question
"I was told it was HA filler."
This story turns on the red flags, not the cosmetic result.
The patient described escalating pain after numbness wore off, inability to sit or walk normally, warmth, swelling, stiffness, and new lumps. When those symptoms worsened, she sought emergency care and reported a cellulitis diagnosis with inpatient treatment.
Severe or worsening pain, spreading redness or heat, fever, drainage, shortness of breath, confusion, weakness, or feeling acutely unwell require prompt medical assessment. A clinic’s text reassurance cannot rule out infection, vascular injury, or another complication.
“Liquid BBL” is a marketing name, not a product identity.
The post says the patient was told the material was hyaluronic acid, but she did not yet know the brand or whether it had been mixed with anything. That uncertainty is clinically important. A record should identify the manufacturer, product, lot number, amount, injection sites, injector, and facility.
FDA guidance recommends against using dermal fillers for body contouring and buttock enlargement. Injectable silicone is not FDA approved for aesthetic body contouring. A familiar facial-filler ingredient does not make a high-volume body injection an approved use.
Before price or volume
Ask for the exact sealed product, manufacturer, lot number, expiration, and FDA-approved indication in writing.
A filler procedure is not a surgical BBL without liposuction.
A surgical Brazilian butt lift transfers the patient’s own fat after liposuction. It carries serious risks and has specific safety recommendations, including keeping fat above the gluteal fascia and using real-time ultrasound guidance. A so-called liquid BBL injects a manufactured or otherwise supplied substance.
The two procedures do not share one risk profile, recovery plan, evidence base, or regulatory status. “No fat harvesting” does not make filler injection a minor substitute.
After a complication, preserve the record before arguing about blame.
Request the treatment consent, invoice, product stickers, lot numbers, injection map, medication record, provider credentials, and every message about symptoms. Hospital clinicians need the best available product information. Regulators and future treating physicians may need it too.
The poster said she intended to file a complaint. Reporting routes depend on provider type and jurisdiction. Immediate medical care comes first; documentation and regulatory questions follow once the patient is safe.
Questions before any body filler
If the provider cannot answer these plainly, stop the appointment.
What exact product and lot will be injected?
Is this use FDA approved?
Who is the licensed injector and who supervises complications?
What volume goes into each anatomical area?
What is the emergency transfer plan?
Which symptoms require an ER rather than a clinic message?
Reddit: the hospitalization account
The patient’s stated volume, price, symptoms, clinic messages, ER visit, cellulitis diagnosis, and hospitalization.
FDA: dermal filler uses and warnings
FDA-approved uses, serious risks, and recommendations against body contouring or buttock enlargement with fillers.
ASPS: gluteal fat-grafting safety advisory
Multi-society guidance on subcutaneous-only fat placement and real-time ultrasound for surgical gluteal fat grafting.
The questions that usually come next
Is liquid BBL the same as a surgical BBL?
No. A surgical BBL transfers the patient’s fat after liposuction. A liquid BBL injects another substance and has different regulatory and safety questions.
Is HA filler FDA approved for buttock enlargement?
FDA guidance recommends against using dermal fillers for body contouring or buttock enlargement.
When should pain after filler be treated as urgent?
Severe or worsening pain, heat, spreading redness, fever, drainage, breathing trouble, confusion, or feeling very unwell need prompt medical assessment.
What records should a patient request?
The exact product, manufacturer, lot, amount, injection sites, consent, invoice, medications, provider credentials, and symptom communications.
Do not compare body-contouring options by downtime alone
Compare the material, anatomical plane, facility, emergency plan, and the evidence behind the procedure.
Research BBL results